News

Axio BioPharma, a trusted innovator and provider of high-quality recombinant proteins, is excited to announce that it is now accepting recombinant protein manufacturing projects. Located within ...
Axio BioPharma Inc., a next-generation biomanufacturing company using AI to transform mammalian protein production, and Likarda Inc., a leader in advanced drug delivery and formulation ...
Medtech startup Axio Biosolutions has raised $5.2 Mn (INR 36 Cr) in Series B-1 round led by Omidyar Network India. Axio’s existing investors Accel, University of California, Ratan Tata-backed ...
Axio BioPharma Inc., a next-generation biomanufacturing company using AI to transform mammalian protein production, and Likarda Inc., a leader in advanced drug delivery and formulation technologies, ...
Partnership combines AI-powered protein manufacturing with advanced drug delivery technologies to accelerate timelines and improve therapeutic outcomes. MADISON, WI and KANSAS CITY, MO, June 9, 2025 - ...
Axio BioPharma and Likarda Announce Strategic Partnership to Accelerate Biologic Drug Development and Delivery PR Newswire MADISON, Wis. and KANSAS CITY, Mo., June 9, 2025 ...